Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.
 

The association between cystatin C and frailty status in older men

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

The association between cystatin C and frailty status in older men

Published Date

2012-05

Publisher

Type

Thesis or Dissertation

Abstract

BACKGROUND Declining kidney function and frailty are common with aging, but the association between these conditions remains uncertain. We hypothesize that cystatin C predicts prevalent frailty status in men age 65 and older. METHODS Serum cystatin C (cys C) and creatinine (Cr) were measured and frailty status ascertained in a random sample of 1602 community-dwelling men age 􀂕 65 yrs participating in the MrOS study. Frailty status (comprised of shrinking, weakness, exhaustion, slowness and low physical activity) was analyzed as an ordinal outcome of robust, intermediate stage, and frail based on the number of frailty components present (0, 1-2, or 􀂕 3 respectively) using a multinomial logistic regression model to simultaneously evaluate the odds of being classified as intermediate vs. robust and frail vs. robust. The base model was adjusted for age, race, and clinical site. RESULTS The mean age of the cohort was 73.8 yrs; 9.8% were frail and 47.2% were intermediate stage. The highest quartile of cys C was associated with more than seven times the odds of being classified as frail vs. robust when compared to the lowest quartile of cystatin C and 2.38 times the odds of being classified as intermediate status. The association was attenuated but persisted after adjusting for health status, body mass index, number of comorbidities, IADL impairments, vitamin D level, serum albumin level, CRP and IL-6 levels. In contrast, neither higher serum Cr (p-value for trend across quartiles > 0.76) nor lower Cr-based eGFR (p-value for trend across quartiles > 0.47) was associated with higher odds of frailty. CONCLUSION Higher cys C was associated with increased odds of frailty status in this cohort of older men whereas Cr-based measures were not. This difference may be due to lower specificity of Cr based measures compared to cys C in older adults with modest reductions in kidney function, or because cys C is associated with frailty by a mechanism that is unrelated to kidney function.

Keywords

Description

University of Minnesota M.S. May 2012. Major : Clinical Research (Renal). Advisors: Areef Ishani and Hassan Ibrahim. 1 computer file (PDF); v, 20 pages, appendices p. 15-30.

Related to

Replaces

License

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Hart, Allyson. (2012). The association between cystatin C and frailty status in older men. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/161736.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.